Sign in

CIK 0001107421

  • Non-accelerated filer
  • Smaller reporting company

Alaunos Therapeutics, Inc.

Sign in to watch
Ticker
TCRT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841475642
Phone
+1 346-355-4099
Business address
501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
Former names
ZIOPHARM ONCOLOGY INC, EASYWEB INC
  1. 4 Grant or award EVP, CLO, and Secretary acquired 21,578 shares (grant or award)
  2. 4 Shares withheld for taxes President, COO & Treasurer gave up 7,908 shares (to pay taxes)
  3. 4 Grant or award Director acquired 17,577 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 38,294 shares at $4.99 ($191,087)
  7. 4 Open-market buy Director bought 461,646 shares at an average $4.92 ($2,272,821)
  8. 4 Open-market buy Director bought 5,000 shares at $5.19 ($25,926)
  9. 4 Open-market buy Director bought 846,522 shares at an average $4.78 ($4,042,234)
  10. 4 Grant or award Executive VP, CMO acquired 50,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale Director sold 15,000 shares at $6.53 ($97,950)
  13. 4 Open-market sale Director sold 15,000 shares at $6.57 ($98,615)
  14. 4 Open-market buy Director bought 1,910,000 shares at $5.75 ($10,982,500)
  15. 4 Open-market buy Director bought 6,063,161 shares at $4.80 ($11,645,928)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Shares withheld for taxes CEO gave up 15,190 shares (to pay taxes)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 17 of 24 · 465 filings